My watch list
my.bionity.com  
Login  

Virus-Like Particles

News Virus-Like Particles

  • A 3D structure of 1918 influenza virus-like particles

    Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs are not infectious, they show considerable promise as vaccine platforms for many viral diseases, including influenza. Realizing that fine details about influenza VLPs were scant, a team o more

  • Pevion launches new immune enhancement platform called Defensomes

    Pevion Biotech AG announced the launch of a new program called Defensomes, a platform for broad spectrum immune enhancement via mechanisms of innate immunity. The proprietary technology is derived from a vaccine platform with a solid safety track record comprising more than 80 million doses applied more

  • DPZ Signs License Agreement with Biogen Idec

    The German Primate Center (DPZ) and its technology transfer partner Ascenion announced the signing of a license agreement providing Biogen Idec with exclusive, worldwide rights to a patent portfolio directed to a recombinant virus-like particle (VLP) containing VP1 protein for the detection of antib more

All news on virus-like particles

White papers Virus-Like Particles

Publications Virus-Like Particles

All publications on virus-like particles

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE